JWH-057

Synthetic cannabinoid
| JWH-057
| |
|---|---|
| Identifiers
| |
| PubChem | 44417060
|
| ChemSpider | 23271524
|
| ChEMBL | 370726 |
| Chemical data
| |
| Chemical formula | C25H25N1O1
|
| SMILES | CCCCCC1=CC2=C(C=C1)C(=CN2)C(=O)C3=CC=C(C=C3)C4=CC=C(C=C4)C
|
JWH-057 is a synthetic cannabinoid from the naphthoylindole family. It was first synthesized by the chemist John W. Huffman and is used in scientific research. JWH-057 acts as a potent agonist at both the CB1 and CB2 cannabinoid receptors.
Chemical properties[edit]
JWH-057 has the IUPAC name (4-methyl-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone. Its molecular formula is C25H25NO, and it has a molecular weight of 359.47 g/mol. The structure consists of a naphthalene ring substituted with a methyl group and a pentylindole moiety.
Pharmacology[edit]
JWH-057 is known to bind to the CB1 and CB2 receptors, which are part of the endocannabinoid system. These receptors are involved in various physiological processes including pain sensation, appetite, and mood. The binding affinity of JWH-057 to these receptors is similar to that of other synthetic cannabinoids, making it a subject of interest in the study of cannabinoid receptor interactions.
Legal status[edit]
The legal status of JWH-057 varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Researchers must often obtain special licenses to work with this compound.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian